HC Wainwright initiates Biodesix coverage with Buy rating
HC Wainwright & Co. initiated coverage on Biodesix with a Buy rating and a price target of $26, as stated by analyst Yi Chen.
*this image is generated using AI for illustrative purposes only.
HC Wainwright & Co. has initiated coverage on Biodesix with a Buy rating and a price target of $26. Analyst Yi Chen issued the rating, highlighting the stock's potential upside.
Analyst Details
The coverage initiation provides a new outlook for Biodesix shares. The price target of $26 suggests significant growth potential from current levels.
| Analyst | Firm | Rating | Price Target |
|---|---|---|---|
| Yi Chen | HC Wainwright & Co. | Buy | $26 |
What specific catalysts does HC Wainwright expect to drive Biodesix's stock toward the $26 price target?
How might Biodesix's recent product developments or partnerships influence its market position in the coming year?
What are the potential risks Biodesix could face that might hinder its ability to meet the projected growth?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
